|
1 Indications And Usage Belviq/belviq Xr Is Indicated As An Adjunct To A Reduced-Calorie Diet And Increased Physical Activity For Chronic Weight Management In Adult Patients With An Initial Body Mass Index (Bmi) Of: 30 Kg/m 2 Or Greater (Obese), Or 27 Kg/m 2 Or Greater (Overweight) In The Presence Of At Least One Weight Related Comorbid Condition (E.g., Hypertension, Dyslipidemia, Type 2 Diabetes) [ See Dosage And Administration ( 2 ) ] Limitations Of Use: The Safety And Efficacy Of Coadministration Of Belviq/belviq Xr With Other Products Intended For Weight Loss Including Prescription Drugs (E.g., Phentermine), Over-The-Counter Drugs, And Herbal Preparations Have Not Been Established. The Effect Of Belviq/belviq Xr On Cardiovascular Morbidity And Mortality Has Not Been Established. Belviq/belviq Xr Is A Serotonin 2c Receptor Agonist Indicated As An Adjunct To A Reduced-Calorie Diet And Increased Physical Activity For Chronic Weight Management In Adults With An Initial Body Mass Index (Bmi) Of: 30 Kg/m 2 Or Greater (Obese) ( 1 ) Or 27 Kg/m 2 Or Greater (Overweight) In The Presence Of At Least One Weight-Related Comorbid Condition, (E.g., Hypertension, Dyslipidemia, Type 2 Diabetes) ( 1 ) Limitations Of Use: The Safety And Efficacy Of Coadministration With Other Products For Weight Loss Have Not Been Established ( 1 ) The Effect Of Belviq/belviq Xr On Cardiovascular Morbidity And Mortality Has Not Been Established ( 1 )
|